PharmaShots | Incisive News in 3 Shots

Subscribe Now

arrivo bioventures

Arrivo BioVentures’ RABI-767 Receives the US FDA’s Fast Track Designation for Treating Acute Pancreatitis

Arrivo BioVentures’ RABI-767 Receives the US FDA’s Fast Track Designation for Treating Acute Pancreatitis

July 15, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us